Detalhe da pesquisa
1.
Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium.
Chest
; 165(3): 653-668, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37977263
2.
Improvements in health status with revefenacin, a once-daily, nebulized, long-acting muscarinic antagonist for chronic obstructive pulmonary disease.
Respir Med
; 208: 107123, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681255
3.
Lung deposition of inhaled once-daily long-acting muscarinic antagonists via standard jet nebulizer or dry powder inhaler, measured using functional respiratory imaging, in patients with chronic obstructive pulmonary disease.
Ther Adv Respir Dis
; 16: 17534666221077561, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35234085